RecruitingNCT06373328

Post Pandemic Pneumococcal Carriage Among Children and Adults

Post-Pandemic Genomic Epidemiology of Pneumococcal Carriage Among Children and Adults in the General US Population


Sponsor

University of Central Florida

Enrollment

900 participants

Start Date

Jun 12, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.


Eligibility

Min Age: 7 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with pneumococcal carriage. The study is currently recruiting participants at 1 location. People eligible for this study include aged 7 Months and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Central Florida

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06373328


Related Trials